Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexS&P 500 P/E- EPS (ttm)-9.10 Insider Own11.44% Shs Outstand255.70M Perf Week-1.36%
Market Cap22.74B Forward P/E19.38 EPS next Y4.59 Insider Trans-0.03% Shs Float226.43M Perf Month-3.62%
Income-2318.00M PEG- EPS next Q0.82 Inst Own80.77% Short Float1.77% Perf Quarter-13.89%
Sales11.42B P/S1.99 EPS this Y25.50% Inst Trans-2.19% Short Ratio2.89 Perf Half Y-8.46%
Book/sh57.78 P/B1.54 EPS next Y9.50% ROA-7.32% Short Interest4.00M Perf Year15.77%
Cash/sh2.22 P/C40.11 EPS next 5Y10.00% ROE-14.60% 52W Range72.94 - 106.77 Perf YTD9.84%
Dividend Est.1.64 (1.84%) P/FCF24.58 EPS past 5Y- ROI-9.65% 52W High-16.70% Beta1.19
Dividend TTM2.01 (2.26%) Quick Ratio1.93 Sales past 5Y31.28% Gross Margin29.52% 52W Low21.93% ATR (14)1.74
Dividend Ex-DateDec 20, 2024 Current Ratio2.62 EPS Y/Y TTM-5139.41% Oper. Margin9.51% RSI (14)36.29 Volatility1.54% 1.91%
Employees21500 Debt/Eq0.66 Sales Y/Y TTM-1.76% Profit Margin-20.30% Recom1.86 Target Price104.95
Option/ShortYes / Yes LT Debt/Eq0.63 EPS Q/Q135.01% Payout- Rel Volume0.39 Prev Close89.13
Sales Surprise3.28% EPS Surprise-3.11% Sales Q/Q3.72% EarningsNov 05 AMC Avg Volume1.38M Price88.94
SMA20-0.65% SMA50-7.61% SMA200-5.46% Trades Volume356,113 Change-0.22%
Date Action Analyst Rating Change Price Target Change
Nov-12-24Upgrade Morgan Stanley Equal-Weight → Overweight $111 → $110
Nov-08-24Upgrade BofA Securities Neutral → Buy $107
Nov-07-24Upgrade Vertical Research Hold → Buy $109
Sep-11-24Reiterated Oppenheimer Outperform $116 → $117
Sep-03-24Upgrade Mizuho Neutral → Outperform $109 → $120
Jul-22-24Upgrade Stifel Hold → Buy $95 → $115
Jun-07-24Initiated Oppenheimer Outperform $116
May-21-24Downgrade Morgan Stanley Overweight → Equal-Weight $100
May-08-24Upgrade JP Morgan Neutral → Overweight $75 → $100
Apr-18-24Upgrade Barclays Underweight → Equal Weight
Dec-05-24 11:30AM
Dec-02-24 08:48AM
Nov-20-24 12:36PM
Nov-14-24 04:00AM
Nov-12-24 12:13AM
09:15AM Loading…
Nov-11-24 09:15AM
Nov-08-24 12:56PM
Nov-07-24 02:01PM
09:35AM
Nov-06-24 04:43PM
12:52PM
12:01AM
Nov-05-24 06:00PM
05:25PM
04:32PM
04:15PM Loading…
04:15PM
Nov-04-24 04:00AM
Oct-31-24 09:15AM
Oct-30-24 04:15PM
Oct-29-24 10:01AM
Oct-24-24 09:00AM
Oct-23-24 01:00AM
Oct-22-24 09:50AM
Oct-21-24 09:00AM
Oct-18-24 11:01AM
Oct-17-24 04:15PM
Oct-16-24 10:08AM
Oct-14-24 09:00AM
Sep-28-24 06:53AM
Sep-27-24 11:27AM
09:00AM Loading…
Sep-26-24 09:00AM
Sep-24-24 03:16AM
Sep-16-24 09:50AM
Sep-08-24 03:04PM
Sep-07-24 07:53PM
Sep-06-24 12:00PM
Sep-05-24 11:31AM
Sep-02-24 06:23PM
Aug-30-24 06:09PM
Aug-27-24 06:07PM
Aug-15-24 04:15PM
Aug-12-24 09:15AM
Aug-08-24 01:16AM
Aug-07-24 04:26PM
02:11PM
Aug-06-24 06:30PM
05:25PM
04:25PM
04:15PM
Aug-05-24 09:04AM
Aug-01-24 09:15AM
Jul-30-24 09:00PM
05:08PM
12:19PM
10:01AM
Jul-09-24 04:15PM
Jun-30-24 09:12AM
Jun-28-24 09:50AM
Jun-26-24 04:00AM
Jun-24-24 06:35AM
Jun-12-24 09:50AM
Jun-05-24 11:30AM
May-30-24 04:15PM
04:15PM
May-29-24 04:15PM
May-27-24 06:00AM
May-21-24 12:30PM
12:22PM
May-15-24 09:00AM
May-14-24 04:01PM
May-13-24 08:59AM
May-10-24 09:27AM
May-09-24 06:43AM
May-08-24 03:30PM
11:18AM
11:11AM
08:34AM
08:05AM
07:36AM
07:00AM
06:52AM
06:52AM
06:52AM
05:44AM
03:21AM
01:06AM
May-07-24 11:13PM
04:48PM
12:47PM
12:42PM
10:29AM
07:43AM
07:39AM
May-06-24 06:12PM
06:00PM
05:55PM
05:30PM
04:58PM
04:38PM
04:16PM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finzel RalfEVP, Global Operations OfficerDec 02 '24Option Exercise0.005,38709,622Dec 03 04:05 PM
Arora YuvrajPresident, NourishNov 11 '24Sale91.755,000458,7753,238Nov 12 04:20 PM
Arora YuvrajOfficerNov 11 '24Proposed Sale91.755,000458,775Nov 12 09:07 AM
RICHTER GLENN RCFOOct 01 '24Option Exercise0.0011,812032,171Oct 03 04:20 PM
Borg DeborahEVP, Chief HR and D&I OfficerSep 03 '24Option Exercise0.0013,807030,282Sep 05 04:05 PM
Herriott SimonPres. Health & BioscienceJul 03 '24Option Exercise0.00627010,759Jul 05 04:10 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Option Exercise77.162,588199,69011,127Jun 14 04:56 PM
Strzelecki AngelaPresident, Pharma SolutionsJun 13 '24Sale95.662,588247,5608,539Jun 14 04:56 PM
Yildiz BerilCAO, SVP & ControllerMay 03 '24Option Exercise0.0084801,588May 07 07:06 PM
O'Byrne KevinDirectorMay 03 '24Option Exercise0.001,67101,933May 07 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsMay 03 '24Option Exercise0.001,06008,868May 07 07:06 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 06 '24Option Exercise0.0072601,178May 07 07:06 PM
Teles de Mendonca Ana PaulaPresident, ScentMay 03 '24Option Exercise0.007070707May 07 07:06 PM
RICHTER GLENN RCFOMay 03 '24Option Exercise0.004,243021,889May 07 07:06 PM
Johnson Jennifer AmyEVP, General CounselMay 03 '24Option Exercise0.002,12107,936May 07 07:04 PM
Hu GaoxiangDirectorMay 03 '24Option Exercise0.001,67102,105May 07 07:04 PM
Herriott SimonPres. Health & BioscienceMay 03 '24Option Exercise0.001,591010,625May 07 07:03 PM
Gold Christina ADirectorMay 03 '24Option Exercise0.001,671010,840May 07 07:03 PM
Finzel RalfEVP, Global Operations OfficerMay 03 '24Option Exercise0.001,32604,770May 07 07:03 PM
Ferguson Roger W. Jr.DirectorMay 03 '24Option Exercise0.002,62502,625May 07 06:56 PM
DAVIDSON CAROL ANTHONYDirectorMay 03 '24Option Exercise0.001,67101,926May 07 06:56 PM
Costa Mark JDirectorMay 03 '24Option Exercise0.001,67102,139May 07 06:55 PM
Bruno Barry A.DirectorMay 03 '24Option Exercise0.001,67103,205May 07 06:55 PM
Borg DeborahEVP, Chief HR and D&I OfficerMay 03 '24Option Exercise0.001,768017,188May 07 06:55 PM
Arora YuvrajPresident, NourishMay 03 '24Option Exercise0.0011,538011,538May 07 06:54 PM
Johnson Jennifer AmyEVP, General CounselApr 05 '24Option Exercise0.0096806,165Apr 09 05:28 PM
Herriott SimonPres. Health & Biosci. & ScentApr 05 '24Option Exercise0.001,59009,496Apr 09 05:26 PM
Strzelecki AngelaPresident, Pharma SolutionsApr 05 '24Option Exercise0.001,14008,162Apr 09 05:25 PM
Herriott SimonPres. Health & Biosci. & ScentApr 01 '24Option Exercise0.001,48908,367Apr 03 04:24 PM
Clyburn FrankChief Executive OfficerMar 01 '24Option Exercise0.001,32402,170Mar 05 07:06 PM
Strzelecki AngelaPresident, Pharma SolutionsJan 03 '24Option Exercise0.001,34107,418Jan 04 04:06 PM